e countries not located in the ICH regions and not covered by ICH Q1 A R2 Stability Testing for New Drug Substances and Drug Products ICH Q1 F described harmonised global stability testing requirements in order to facilitate access to medicines by re ID: 67707
Download Pdf The PPT/PDF document "Explanatory Note on the Withdrawal of IC..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
